Viewing Study NCT00107094


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-01-27 @ 6:08 AM
Study NCT ID: NCT00107094
Status: COMPLETED
Last Update Posted: 2007-07-20
First Post: 2005-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer
Sponsor: Celgene Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module